2023 International Congress » Other

A retrospective comparison between EMG and US-guided botulinum injections for cervical dystonia

V. Livneh, A. Socher, M. Cohen, Y. Schechter, I. Israel, T. Gurevic, G. Yahalom (Tel Aviv, Israel)

Adequate hydration with personalized diet improves bowel function and mobility for people with Parkinson’s (PwP’s) on levodopa/carbidopa intestinal gel (LCIG) infusion therapy

Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

Age-associated changes in the striatal proteins in aging Asian-Indians

H J. Jyothi, A. Mahadevan, T C. Yasha, P. Alladi (Bengaluru, India)

An European-Canadian multinational evaluation of access to care in Parkinson disease: a patient perspective

M. van Munster, E. Crighton, A. Sánchez-Ferro, J. Ferreira, R. Bouça, E. Ruzicka, D. Pedrosa, D. Grimes, T. Mestre (Marburg, Germany)

Asian LRRK2 variants do not increase Likelihood Ratios derived from MDS prodromal Parkinson’s Disease criteria in a community population

R. Chen, C. Chai, N. Chia, S. Ng, E. Ng, E. Tan, Z. Xu, L. Tan (Singapore, Singapore)

Association between lifestyle and environmental factors with disease severity and age at onset in multi-ethnic Malaysian Parkinson’s disease patients

JP. Schee, HC. Ting, ZL. Loo, AMF. Dy Closas, TS. Toh, JW. Hor, YW. Tay, JL. Lim, LC. Lit, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

Ataxia, deafness, aphonia associated with ANNA-1/ /”anti-Hu” and LUZP4 antibodies

R. Vasireddy, M. Thandampallayam, P. Sudhakar, Z. Guduru (Lexington, USA)

Breast carcinoma presenting with anti-amphiphysin antibody-associated stiff-limb syndrome

AM. Dy Closas, AH. Tan, KJ. Goh, JP. Schee, MH. See, SML. Tai, SY. Lim (Kuala Lumpur, Philippines)

Case Report: Supranuclear Palsy and Increased Intraocular Pressure in Normal Pressure Hydrocephalus

K. Young, M. Gates (Austell, USA)

Characterization of gait variability of early Parkinson’s disease and multiple system atrophy

M. Jecmenica Lukic, A. Tomic, I. Stankovic, V. Markovic, N. Kresojevic, N. Dragasevic, M. Svetel, I. Petrovic, S. Radovanovic, V. Kostic (Belgrade, Serbia)

Choroidal changes in Parkinson’s disease: A longitudinal follow up study

P. Mailankody, R. Battu, PM. Pm, T. K, N. Kamble, R. Yadav, P. Pal (Bangalore, India)

Classification of Obstructive Sleep Apnea based on Statistical Features of the RR Interval using the Support Vector Machine Algorithm

R. Fajar, E. Syafruddin, S. Putry (Sleman, Indonesia)

Clinical Phenotypes and Imaging Localization of Movement Disorders after Acute Stroke

E. Samra, T. Roushdy, A. Saeed, A. Mansour, A. Elbassiouny, A. Shalash (Kafr Elsheikh, Egypt)

Complex movement disorder presentations of autoimmune encephalitis – recovery at 4 weeks versus 4 years

L. Jaffe (Honolulu, USA)

Dietary protein redistribution influences the efficacy of levodopa/carbidopa intestinal gel (LCIG) infusion

Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

Education and the motor effects of dopamine loss in Parkinson’s disease

M. Hoenig, V. Dzialas, M. Banwinkler, A. Asendorf, T. van Eimeren (Juelich, Germany)

Effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder

T. Uchiyama, T. Yamamoto, R. Sakakibara, S. Kuwabara, H. Murai (Chiba, Japan)

Effect of the COVID-19 pandemic on gait and other motor and non-motor symptoms in people with Parkinson’s disease

A. Boddu, A. Glover, L. Pillai, T. Virmani (Little Rock, USA)

Experience of Quality of Life in German Persons living with Parkinson’s Disease: A Qualitative Exploration

M. van Munster, M. Stührenberg, A. Pedrosa Carrasco, D. Pedrosa (Marburg, Germany)

From the Healthy Brain Ageing – HeBA – Cohort: Motivation for participating in the first online phase of HeBA

P. Mahlknecht, T. Marques, C. Vega Moreno, C. Horlings, A. Garrido, S. Schade, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Seppi, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krueger, B. Mollenhauer, M. Marti (Innsbruck, Austria)

From the Healthy Brain Ageing (HeBA) Cohort: Frequency of key risk factors for Parkinson in a European Cohort

A. Garrido, C. Horlings, C. Vega, S. Schade, S. Ghosh, K. Rege, R. Rawal, T. Marques, P. Mahlknecht, C. Gomes, C. Pauly, D. Mcintyre, K. Seppi, MJ. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

Impact of culture on Impulse control disorders and correlation with levodopa-induced dyskinesia in Parkinson’s disease in Egypt .

AHM. Mahmoud (Tahta, Egypt)

Impact of Decreased Cognitive Function on the Risk of Falling in the Elderly

R. Nindela, N. Sitohang, S. Marisdina (Palembang, Indonesia)

Integrating care coordination into telemedicine services provides a better patient experience than care coordination alone: Insights from a national neurodegenerative disease telemedicine program

J. Hatcher-Martin, C. Byrne, E. Anderson (Chicago, USA)

Making Parkinson’s care complete and global: an international survey of the “vitals” dashboard of Parkinson’s disease

M. Qamar, C. Falup-Pecurariu, L. Batzu, A. Podlewska, S. Rota, N. Titova, V. Metta, I. Murasan, D. Ziemele, R. van Coller, J. Carr, G. Chung-Faye, L. Ungureanu, K. Ray Chaudhuri (London, United Kingdom)

Measures of trancranial magnetic evoked potentials for prediction of response to ventriculoparitoneal shunt In normal pressure hydrocephalus

T. Davidy, S. Anis, A. Sominski, J. Zauberman, T. Fay-Karmon, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)

Meige Syndrome Following COVID Infection

E. Girouard, A. Levy (Montréal, Canada)

Movement disorders in the setting of dengue infection in a rural medical teaching hospital in Gujarat, India

D. Desai, S. Desai (Anand, India)

Navigating Open Science in Canada with the Canadian Open Parkinson Network

M. Cressatti, C. Normandeau, C. Degroot, I. Kathol, A. Stoessl, M. Mckeown, J. Miyasaki, R. Camicioli, D. Grimes, L. Kalia, A. Strafella, P. Macdonald, N. Dupré, E. Fon, O. Monchi (Calgary, Canada)

Needs assessment of patients with Parkinson’s disease: a qualitative study

N. Geraminejad, A. Darvishpoor Kakhki (Tehran, Islamic Republic of Iran)

Patients activation in people with Parkinson disease and its relation to personal factors

B. Naamneh Abuelhija, M. Kafri, M. Kestenbaum, S. Giveon, G. Yogev-Seligmann (Haifa, Israel)

Predictors of death in Parkinson’s disease

M. Garon, L. Weis, F. Pistonesi, V. Cianci, N. Cazzola, ML. Nasi, R. Biundo, A. Antonini (padova, Italy)

Rapidly progressive fatal dystonia in an adult.

D. Joshi, A. Kumar, S. Parida, S. Pattanayak (Varanasi, India)

Safety and performance of DBS primary cell IPG replacement: An interim report from the ADROIT study

S. Groppa, J. Muñoz, K. Ashkan, A. Gharabaghi, T. Tomlinson, M. Frassica, M. Navas Garcia (Mainz, Germany)

Serum levels of IL-1β and interleukin 6 in Parkinson’s disease

S. Fezai, M. Ben Mahmoud, S. Fray, H. Jamoussi, N. Ben Ali, M. Fredj (Tunis, Tunisia)

Stiff-person syndrome associated with anti-Yo1 antibodies: a case report

E. Chekanova, I. Luneva, A. Kozlova, O. Smetanina, M. Zakharova (Moscow, Russian Federation)

Subacute Encephalopathy with Seizures in Alcohol Consumers (SESA) presenting as Focal Dyskinesias and Myoclonus

D. Desai, S. Desai (Anand, India)

SYNCHRONIZE: Real-world retrospective safety analysis in patients treated with onabotulinumtoxinA for more than one therapeutic indication

A. Patel, G. Forde, K. Martinez, A. Mayadev, B. Brucker, K. Becker Ifantides, R. Singh, M. Nelson, I. Yushmanova, S. Battucci, C. Rhyne (Overland Park, USA)

The effect of anti- Parkinson’s disease granules and probiotics on gastrointestinal motility in the mouse model of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine -induced Parkinson’s disease

X. Zhao, J. Yang (Shanghai, China)

The Healthy Brain Ageing (HeBA) Parkinson’s disease risk survey: Study design and methods

C. Horlings, A. Garrido, C. Vega Moreno, S. Schade, T. Marques, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Marini, K. Seppi, M. Marti, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Innsbruck, Austria)

The Quebec Parkinson Network (QPN): Interdisciplinary Collaboration in Parkinson’s Disease and Related Disorders Research.

M. Blais, S. Bogard, C. Degroot, N. Dupré, E. Fon (Quebec City, Canada)

The spatial and spectral organization of thalamo-cortical connectivity in patients with essential tremor

A. Steina, S. Schnitzler, J. Vesper, E. Florin, A. Schnitzler, J. Hirschmann (Düsseldorf, Germany)

Tongue fasciculations and numbness: A case of calcifying pseudoneoplasm

S. Hudaib, N. Stubbs, L. Simon, V. Blake, E. Nduom, C. Branson (Atlanta, USA)

Towards smart glasses for improved care of individuals with Parkinson’s disease

I. Kiprijanovska, F. Panchevski, S. Stankoski, M. Gjoreski, J. Archer, J. Broulidakis, I. Mavridou, B. Hayes, T. Guerreiro, C. Nduka, H. Gjoreski (Brighton, United Kingdom)

Transforming Parkinson’s Care in Africa: community engagement and involvement activities

N. Fothergill-Misbah, R. Walker (Newcastle Upon Tyne, United Kingdom)

Validation and psychometric properties of the Thai version of the hemifacial spasm grading questionnaire (HFS score) for physician-assessed clinical involvement and patient-reported health-related quality of life: a prospective observational study

���N. Likhitwitayawuid, Y. Pitakpatapee, W. Saengphatarachai, P. Srivanitchapoom (Bangkok, Thailand)

Variant frequencies in dystonia and Parkinson’s disease genes cross phenotypic boundaries

L. Lange, A. Illarionova, K. Grütz, EJ. Vollstedt, B-H. Laabs, S. Löns, G. Kilic-Berkmen, F. Hinrichs, H. Padlock, L. Screven, T. Bäumer, H. Jinnah, N. Brüggemann, Z-H. Fang, K. Lohmann, C. Klein (Luebeck, Germany)